Valuation (36%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 32.87 | N/A |
| PEG Ratio (TTM) | -3.72 | N/A |
| P/S Ratio (TTM) | 3.62 | N/A |
| P/B Ratio (TTM) | 2.11 | N/A |
| P/FCF Ratio (TTM) | 20.33 | N/A |
| Price to 5YR AVG Earnings Ratio | N/A | N/A |
| Price to 5YR AVG FCF Ratio | N/A | N/A |
Profitability (20%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 4.10% | N/A |
| ROE (TTM) | 6.58% | N/A |
| Net Profit Margin (TTM) | 10.95% | N/A |
| ROIC 5YR AVG | N/A | N/A |
Growth (32%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -2.48% | 45.64% | N/A |
| Revenue | -1.11% | 4.34% | N/A |
| Net Income | -2.50% | 43.98% | N/A |
| Cash Flow | 2.86% | 120.86% | N/A |
Health (53%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 2.42 | N/A |
| Quick Ratio (TTM) | 1.76 | N/A |
| D/E Ratio (TTM) | 0.21 | N/A |
| Interest Coverage (TTM) | N/A | N/A |
| Piotroski F-Score | 7 | N/A |
| Altman Z-Score | 2.15 | N/A |
| LTL to 5YR AVG FCF | N/A | N/A |
| Shares Outstanding Growth 5YR AVG | N/A | N/A |